Detalles de la búsqueda
1.
Pathophysiological Sex Differences in Heart Failure Progression After Acute Coronary Syndrome: Insights From the EXAMINE Trial.
J Card Fail
; 2023 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37939897
2.
External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial.
Diabetes Obes Metab
; 25(1): 229-237, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082521
3.
Optimal promising zone designs.
Biom J
; 61(5): 1175-1186, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30411405
4.
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).
Circulation
; 135(20): 1911-1921, 2017 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28246236
5.
A randomized, controlled trial of oral propranolol in infantile hemangioma.
N Engl J Med
; 372(8): 735-46, 2015 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25693013
6.
A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks.
Biometrics
; 74(1): 40-48, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28589692
7.
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Diabetes Obes Metab
; 19(5): 664-671, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28058763
8.
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.
Lancet
; 385(9982): 2067-76, 2015 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25765696
9.
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
N Engl J Med
; 369(14): 1327-35, 2013 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23992602
10.
Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial.
Am Heart J
; 175: 18-27, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27179720
11.
Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (I): unknown correlation between the endpoints.
Stat Med
; 31(19): 2027-40, 2012 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22729929
12.
Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
Stat Med
; 31(19): 2041-54, 2012 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22733687
13.
Adaptive increase in sample size when interim results are promising: a practical guide with examples.
Stat Med
; 30(28): 3267-84, 2011 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22105690
14.
Comments on "Some Challenges with Statistical Inference in Adaptive Designs" by Hung, Wang, and Yang.
J Biopharm Stat
; 26(2): 402-4, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26428953
15.
Population enrichment designs: case study of a large multinational trial.
J Biopharm Stat
; 21(4): 831-45, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21516572
16.
Testing a primary and a secondary endpoint in a group sequential design.
Biometrics
; 66(4): 1174-84, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20337631
17.
Exact confidence bounds following adaptive group sequential tests.
Biometrics
; 65(2): 539-46, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18759843
18.
Adaptive clinical trial designs with pre-specified rules for modifying the sample size: a different perspective.
Stat Med
; 32(8): 1276-9, 2013 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23494662
19.
The distance of the femoral neurovascular bundle from the hip joint: an intraoperative guide to reduce iatrogenic injury.
J Orthop Surg Res
; 13(1): 135, 2018 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29866137
20.
Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial.
Diabetes Care
; 41(12): 2603-2609, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30459247